Investor Update
Basel, 01 July 2011
Chronic Hepatitis C Treatment, Pegasys®, and Antiviral Drug, Copegus®, Obtained Approval for Additional Indication of Compensated Liver Cirrhosis Related to Hepatitis C
Dear Investor,
Please find attached a press release by Chugai.
Do not hesitate to contact us for any further questions.